๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The importance and benefits of hepatitis A prevention in chronic liver disease patients

โœ Scribed by GRAHAM COOKSLEY

Book ID
108949790
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
62 KB
Volume
19
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety and immunogenicity of hepatitis A
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
โœ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated
Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease
โœ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 298 KB ๐Ÿ‘ 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec